Show simple item record

dc.contributor.authorGhaderi, F
dc.contributor.authorNemati, M
dc.contributor.authorSiahi-Shadbad, MR
dc.contributor.authorValizadeh, H
dc.contributor.authorMonajjemzadeh, F
dc.date.accessioned2018-08-26T08:52:03Z
dc.date.available2018-08-26T08:52:03Z
dc.date.issued2016
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/53609
dc.description.abstractIn the present paper, the physicochemical incompatibility of doxepin with dextrose was evaluated in solid-state mixtures. The compatibility was evaluated using different physicochemical methods such as differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy and mass spectrometry. Non-isothermally stressed physical mixtures were used to study the solid-state kinetic parameters. Different thermal models such as Friedman, Flynn-Wall-Ozawa and Kissinger-Akahira-Sunose were used for the characterization of the drug-excipient mixtures. Overall, the incompatibility of doxepin as a tertiary amine with dextrose as a reducing carbohydrate was successfully assessed. DSC-based kinetic analysis is a simple and fast method in evaluation of different drug-excipient mixtures incompatibility. Finally, it can be recommended to exclude dextrose from doxepin pharmaceutical formulations and also to apply the easy and versatile DSC method in kinetic study of drug-excipient incompatibility. آ© 2015 Akadأ©miai Kiad?, Budapest, Hungary.
dc.language.isoEnglish
dc.relation.ispartofJournal of Thermal Analysis and Calorimetry
dc.subjectDextrose
dc.subjectDifferential scanning calorimetry
dc.subjectDrug products
dc.subjectFourier transform infrared spectroscopy
dc.subjectKinetic theory
dc.subjectMass spectrometry
dc.subjectMixtures
dc.subjectDoxepin
dc.subjectDSC
dc.subjectIncompatibility
dc.subjectMass
dc.subjectPharmaceutical formulation
dc.subjectPhysicochemical methods
dc.subjectSolid state mixtures
dc.subjectSolid-state kinetics
dc.subjectKinetics
dc.titleDSC kinetic study of the incompatibility of doxepin with dextrose: Application to pharmaceutical preformulation studies
dc.typeArticle
dc.citation.volume123
dc.citation.issue3
dc.citation.spage2081
dc.citation.epage2090
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.1007/s10973-015-4995-0


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record